Nathan Rich
Stock Analyst at Goldman Sachs
(1.04)
# 3,659
Out of 4,876 analysts
84
Total ratings
35.48%
Success rate
-10.16%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $20.41 | +2.89% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $156.17 | +25.50% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $15.93 | +88.32% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $8.13 | -1.60% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $19.67 | -11.03% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $241.88 | +59.17% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $14.29 | -2.03% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $16.76 | -34.37% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $188.52 | +19.35% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $531.32 | +22.34% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $68.49 | +28.49% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $13.85 | -13.36% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $73.27 | +16.01% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $9.01 | +22.09% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $297.05 | +12.78% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $309.11 | +73.08% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $20.41
Upside: +2.89%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $156.17
Upside: +25.50%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $15.93
Upside: +88.32%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $8.13
Upside: -1.60%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $19.67
Upside: -11.03%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $241.88
Upside: +59.17%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $14.29
Upside: -2.03%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $16.76
Upside: -34.37%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $188.52
Upside: +19.35%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $531.32
Upside: +22.34%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $68.49
Upside: +28.49%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $13.85
Upside: -13.36%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $73.27
Upside: +16.01%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $9.01
Upside: +22.09%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $297.05
Upside: +12.78%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $309.11
Upside: +73.08%